An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers.

Antoine Lewin Steven J DrewsRyanne Lieshout-KrikkeChristian ErikstrupSahar SaeedHelen M FaddySamra UzicaninBrian S Custer Sheila F O'Briennull null

Published in: Vox sanguinis (2021)

Our results highlight the diversity of assays being used. Analyses comparing blood donor seroprevalence across countries should consider assay characteristics with optimization of signal/cut-off ratios and consistent methodology to adjust for waning antibody.

Keyphrases

sars cov
high throughput
respiratory syndrome coronavirus
single cell
coronavirus disease
clinical evaluation